John R Fischer

PE pursues medical textile businesses: 8 deals

Montagu, Kohlberg, Sterling and Arlington are among the PE dealmakers transacting in the medical textiles sector.

Ardian, Sagemount, Eir, Thoma Bravo back life sciences software; 1315 Capital eyes value creation potential in Argonaut’s diagnostics division

AI and regulatory complexity are driving demand for life sciences software, which in turn has attracted private equity; 1315 Capital closes a carve-out deal with a portfolio company of Telegraph Hill Partners and New Vale Capital.

Regulatory pressures, AI opportunities draw PE to life sciences software: 8 deals

Ardian, Bregal Sagemount, Riverside and Thoma Bravo are among the PE dealmakers targeting investments in the life sciences software market.

Flexpoint, Frazier, WindRose eye specialty pharmacies; Pharmacy tech needs drive HIG to back Outcomes One

Multi-state, specialty pharmacies with robust margins and revenues are primary targets for PE dealmakers; a look at HIG Capital’s acquisition of Outcomes One, a provider of clinical network services and pharmacy technology.

Predictable revenues pull PE to specialty pharmacies: 5 deals

Court Square, Frazier Healthcare, Linden Capital and WindRose are among the PE firms investing in specialty pharmacies.

KKR to sell minority stake in Nordic Bioscience to company founder

KKR helped the business double its revenue and expand its capabilities across R&D services, clinical diagnostics and drug development.

Frazier Healthcare Partners snaps up EHR and RCM software provider MatrixCare

Frazier Healthcare Partners plans to support MatrixCare's growth by investing in product innovation and post-acute care capabilities.

HIG Capital acquires Outcomes One

Outcomes One provides clinical network services and pharmacy technology to US pharmacies, healthcare plans, pharmaceutical manufacturers and data partners.

Blue Sea Capital completes acquisition of CompletePet from Align Capital Partners

Align Capital Partners formed CompletePet in 2025 by merging Custom Veterinary Services and Green Mountain Animal.

Main, New Mountain, Marlin Equity target patient engagement tech; Specialty pharmacy, mental health needs drive Flexpoint’s sale of ArtesRx

New software, including agentic AI applications, are fueling provider adoption of patient engagement technology, and PE dealmakers see opportunities to scale these capabilities further; exploring Flexpoint Ford's sale of ArtesRx, a behavioral health pharmacy, to Linden Capital Partners.